Discoid and/or subacute cutaneous lupus erythematosus (dle/scle)

Clinical trials for Discoid and/or subacute cutaneous lupus erythematosus (dle/scle) explained in plain language.

Never miss a new study

Get alerted when new Discoid and/or subacute cutaneous lupus erythematosus (dle/scle) trials appear

Sign up with your email to follow new studies for Discoid and/or subacute cutaneous lupus erythematosus (dle/scle), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Lupus drug continuation trial offers hope for disease control

Disease control Recruiting now

This study offers continued treatment with deucravacitinib for people with systemic lupus erythematosus (SLE) or related skin lupus who finished earlier trials. It aims to keep the disease under control by providing ongoing access to the medication. Only 35 participants are being…

Matched conditions: DISCOID AND/OR SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS (DLE/SCLE)

Phase 4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control

Last updated Sep 11, 2026 00:00 UTC

Discoid and/or subacute cutaneous lupus erythematosus (dle/scle)

Get alerted when new Discoid and/or subacute cutaneous lupus erythematosus (dle/scle) trials appear

Lupus drug continuation trial offers hope for disease control